Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: A cohort study

Circulation: Cardiovascular Imaging

Volumn 3, Issue 3, 2010, Pages 240-248

  Abdelmoneim, Sahar S ^a   Bernier, Mathieu ^a   Scott, Christopher G ^a   Dhoble, Abhijeet ^a   Ness, Sue Ann C ^a   Hagen, Mary E ^a   Moir, Stuart ^a   McCully, Robert B ^a   Pellikka, Patricia A ^a   Mulvagh, Sharon L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Contrast echocardiography; Pulmonary hypertension; Safety; Stress echocardiography

Indexed keywords

CONTRAST MEDIUM; DOBUTAMINE; ALBUMINOID; DIAGNOSTIC AGENT; FLUOROCARBON; PERFLUTREN;

ABDOMINAL PAIN; AGED; ARTICLE; BACKACHE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEADACHE; HEART DEATH; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA AND VOMITING; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHIVERING; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; THROAT IRRITATION; TREMOR; TRICUSPID VALVE REGURGITATION; WHEEZING; BLOOD PRESSURE; COHORT ANALYSIS; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEASIBILITY STUDY; HEART ARRHYTHMIA; HEART INFARCTION; HEART RIGHT VENTRICLE FUNCTION; IMAGE ENHANCEMENT; METHODOLOGY; MICROBUBBLE; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SURVIVAL; TRICUSPID VALVE;

AGED; ALBUMINS; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; COHORT STUDIES; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, STRESS; FEASIBILITY STUDIES; FEMALE; FLUOROCARBONS; HUMANS; HYPERTENSION, PULMONARY; IMAGE ENHANCEMENT; MALE; MICROBUBBLES; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRICUSPID VALVE; TRICUSPID VALVE INSUFFICIENCY; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 77953640671     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.109.895029     Document Type: Article

References (26)

1. FDA. United States Food and Drug Administration Center for Drug Evaluation and Research Alert for Healthcare Providers. Available at: http://www.fda.gov/cder/drug/infopage/microbubble/default.
2. Douglas PS WA, Lindner JR, Wei K. Contrast echocardiography: past, present, and. future? J Am Coll Cardiol Imgaging. 2008;1:107-110.
3. Currie PJ, Seward JB, Chan KL, Fyfe DA, Hagler DJ, Mair DD, Reeder GS, Nishimura RA, Tajik AJ. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750-756.
4. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol. 1987;9:549-554.
5. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-1457.
6. Abdelmoneim SS, Bernier M, Scott CG, Dhoble A, Ness SA, Hagen ME, Moir S, McCully RB, Pellikka PA, Mulvagh SL. Safety of contrast agent use during stress echocardiography: a 4-year experience from a singlecenter cohort study of 26,774 patients. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:1048-1056.
7. Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM, Burns PN, Castello R, Coon PD, Hagen ME, Jollis JG, Kimball TR, Kitzman DW, Kronzon I, Labovitz AJ, Lang RM, Mathew J, Moir WS, Nagueh SF, Pearlman AS, Perez JE, Porter TR, Rosenbloom J, Strachan GM, Thanigaraj S, Wei K, Woo A, Yu EH, Zoghbi WA. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr. 2008;21:1179 -1201, 2008; quiz 1281.
8. Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007;20:1021-1041.
9. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography, II: dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc. 1995;70:16-27.
10. Roger VL, Pellikka PA, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography, I: exercise echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc. 1995; 70:5-15.
11. Hatle L, Angelsen BA, Tromsdal A. Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound. Br Heart J. 1981; 45:157-165.
12. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol. 1990;66:493-496.
13. Commission on Professional and Hospital Activities NCfHSUS. H-ICDA; Hospital Adaptation of ICDA. II ed. Ann Arbor, Mich: Commission on Professional and Hospital Activities; 1973.
14. Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest. 2005;127:1836-1843.
15. Contal C, O'Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comp Stat Data Analysis. 1999;30:253-270.
16. Herzog C. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography. JAMA. 2008;299:2023-2025.
17. Gabriel RS, Smyth YM, Menon V, Klein AL, Grimm RA, Thomas JD, Sabik EM. Safety of ultrasound contrast agents in stress echocardiography. Am J Cardiol. 2008;102:1269-1272.
18. Shaikh K, Chang SM, Peterson L, Rosendahl-Garcia K, Quinones MA, Nagueh SF, Kurrelmeyer K, Zoghbi WA. Safety of contrast administration for endocardial enhancement during stress echocardiography compared with noncontrast stress. Am J Cardiol. 2008;102:1444-1450.
19. Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, Bierig M, Mulvagh SL, Porter TR, Labovitz AJ. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol. 2009;53: 32-38.
20. Nucifora G, Marsan NA, Siebelink HM, van Werkhoven JM, Schuijf JD, Schalij MJ, Poldermans D, Holman ER, Bax JJ. Safety of contrastenhanced echocardiography within 24 h after acute myocardial infarction. Eur J Echocardiogr. 2008;9:816-818.
21. Aggeli C, Giannopoulos G, Roussakis G, Christoforatou E, Marinos G, Toli C, Pitsavos C, Stefanadis C. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for detection of ischemia in 5250 studies. Heart. 2008;94:1571-1577.
22. Tsutsui JM, Elhendy A, Xie F, O'Leary EL, McGrain AC, Porter TR. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol. 2005;45:1235-1242.
23. Kusnetzky LL, Khalid A, Khumri TM, Moe TG, Jones PG, Main ML. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies. J Am Coll Cardiol. 2008;51:1704-1706.
24. Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol. 2008;102:1742-1746.
25. Wei K, Mulvagh SL, Carson L, Davidoff R, Gabriel R, Grimm RA, Wilson S, Fane L, Herzog CA, Zoghbi WA, Taylor R, Farrar M, Chaudhry FA, Porter TR, Irani W, Lang RM. The safety of Definity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr. 2008;21: 1202-1206.
26. Kane GC, Hepinstall MJ, Kidd GM, Kuehl CA, Murphy AT, Nelson JM, Schneider L, Stussy VL, Warmsbecker JA, Miller FA Jr, Pellikka PA, McCully RB. Safety of stress echocardiography supervised by registered nurses: results of a 2-year audit of 15,404 patients. J Am Soc Echocardiogr. 2008;21:337-341.